NC startup focused on reducing surgery radiation exposure sells $4.6M stake — 5 things to know

Written by Megan Wood | February 27, 2017 | Print  |

TrackX Technology, a Durham, N.C.-based biotechnology company, sold a multi-million dollar stake, according to WRAL TechWire.

Here are five things to know:

 

1. The $4.6 million equity will go toward the company's working capital.

 

2. Twenty-three investors participated in the equity round.

 

3. TrackX is currently developing a medical device intended to decrease radiation exposure during surgeries, as reported by WRAL TechWire.

 

4. TrackX listed Robert Isaacs, MD, a Durham-based Duke Health neurosurgeon, as a company director and promoter on its recent Securities and Exchange Commission filing.

 

5. Dr. Isaacs completed his endoscopic and complex spine surgery fellowship at Rush University, Chicago Institute of Neurosurgery and Neuroresearch.

 

More articles on devices:
Medtronic, Exactech, RTI Surgical & more: 9 device company key notes
AxioMed president comments on outpatient cervical disc replacement study: 5 observations
North America leads global neurosurgery market — 5 observations

 

© Copyright ASC COMMUNICATIONS 2019. Interested in LINKING to or REPRINTING this content? View our policies here.

Top 40 Articles from the Past 6 Months